US stock · US markets · public data

RPRX

Royalty Pharma plc · Healthcare

Reference price$58.49Updated according to the public source
P/E31.11
P/B3.82
ROE13.97%
DY 12M1.56%
Net margin—
Net debt/equity—
Market capUS$ 33.8 B
Volume (shares)946,958
SectorHealthcare
Overview

About RPRX

Demonstrações públicas consolidadas + SEC Company Facts

Royalty Pharma plc (RPRX) is a stock traded in US markets in the Healthcare sector. Revenue (FY2025): US$ 2.38 B. Net income (FY2025): US$ 770.9 M. Operating cash flow (FY2025): US$ 2.49 B.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: FY2025.

Distributions

Dividends and distributions · last 12 records

public data
09/23
12/23
03/24
06/24
09/24
12/24
03/25
06/25
09/25
12/25
03/26
06/26
Income in shown records$2.59
DY 12M1.56%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo pago$0.235
Period ending 2026-03-31Dividendo pago$0.235
Period ending 2025-12-31Dividendo pago$0.22
Period ending 2025-09-30Dividendo pago$0.22
Period ending 2025-06-30Dividendo pago$0.22
Period ending 2025-03-31Dividendo pago$0.22

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Latest fiscal period: FY2025 (2025-01-01 – 2025-12-31).

Income statement

Account2022202320242025
Revenue$2,237,215,000.00$2,354,554,000.00$2,263,576,000.00$2,378,193,000.00
Operating Income$307,065,000.00$1,492,150,000.00$1,292,444,000.00$1,559,518,000.00
Net Income$42,832,000.00$1,134,834,000.00$858,983,000.00$770,947,000.00
EPS Diluted$0.10 / share$2.53 / share$1.91 / share$1.78 / share

Balance sheet

Account2022202320242025
Total Assets$16,813,466,000.00$16,381,851,000.00$18,222,715,000.00$19,620,780,000.00
Total Liabilities$7,288,093,000.00$6,297,562,000.00$7,880,349,000.00$9,905,841,000.00
Total Equity$9,525,373,000.00$10,084,289,000.00$10,342,366,000.00$9,714,939,000.00
Long-term Debt$6,118,810,000.00$6,135,285,000.00$6,614,653,000.00$8,570,917,000.00
Current Debt$997,512,000.00$0.00$997,773,000.00$380,000,000.00
Cash & Investments$1,710,751,000.00$477,010,000.00$929,026,000.00$618,696,000.00
Dívida Líquida$5,405,571,000.00$5,658,275,000.00$6,683,400,000.00$8,332,221,000.00

Cash flow

Account2022202320242025
Operating Cash Flow$2,143,980,000.00$2,987,802,000.00$2,768,986,000.00$2,489,823,000.00
FAQ

Frequently asked questions

What is the price of RPRX?

The reference price available for RPRX is $58.49.

What is the P/E of RPRX?

The P/E ratio of RPRX is 31.11. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of RPRX?

The P/B of RPRX is 3.82. This compares price with reported book value per share.

What is the ROE of RPRX?

The ROE (Return on Equity) of RPRX is 13.97%. This relates the reported net result to shareholders' equity.

What is the dividend yield of RPRX?

The dividend yield of RPRX is 1.56%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of RPRX?

The market capitalization of RPRX is US$ 33.8 B.

What sector is RPRX in?

RPRX operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.